Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early sacubitril/valsartan versus valsartan after acute myocardial infarction
ChiCTR2300074600Phase 4Recruiting
- Sponsor
- The First People's Hospital of Shangqiu
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sacubitril + valsartan and valsartan in myocardial infarction (MI) (2 arms), sponsored by The First People's Hospital of Shangqiu. Primary endpoints: Blood routine, hs-CRP and 8 more. Started Nov 2021; status: recruiting.
02
Drugs
sacubitril + valsartanvalsartan
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR2300074600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074600.